{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["23(1)"],"submitter":["Al-Jedai A"],"journal":["Cost effectiveness and resource allocation : C/E"],"pagination":["40"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC12326838"],"repository":["biostudies-literature"],"pubmed_title":["Pioneering SMA therapies for all types: survival gains, cost dynamics, and performance-based agreements."],"pmcid":["PMC12326838"],"pubmed_authors":["Ojeil R","Al-Mudaiheem H","Awad N","AlSakran A","Almuhaizea MA","AlSamman A","Ghamdi F","Al-Jedai A","Bashiri FA"],"additional_accession":[]},"is_claimable":false,"name":"Pioneering SMA therapies for all types: survival gains, cost dynamics, and performance-based agreements.","description":null,"dates":{"release":"2025-01-01T00:00:00Z","publication":"2025 Aug","modification":"2026-03-31T11:59:05.734Z","creation":"2025-09-01T03:08:29.462Z"},"accession":"S-EPMC12326838","cross_references":{"pubmed":["40765022"],"doi":["10.1186/s12962-025-00647-3"]}}